84 related articles for article (PubMed ID: 27897040)
1. Identification of novel genes by whole-exome sequencing can improve gastric cancer precision oncology.
Lianos GD; Glantzounis GK; Bali CD; Katsios C; Roukos DH
Future Oncol; 2017 Apr; 13(10):883-892. PubMed ID: 27897040
[TBL] [Abstract][Full Text] [Related]
2. Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine.
Röcken C; Amallraja A; Halske C; Opasic L; Traulsen A; Behrens HM; Krüger S; Liu A; Haag J; Egberts JH; Rosenstiel P; Meißner T
Genome Med; 2021 Nov; 13(1):177. PubMed ID: 34749812
[TBL] [Abstract][Full Text] [Related]
3. Ontology-based prediction of cancer driver genes.
Althubaiti S; Karwath A; Dallol A; Noor A; Alkhayyat SS; Alwassia R; Mineta K; Gojobori T; Beggs AD; Schofield PN; Gkoutos GV; Hoehndorf R
Sci Rep; 2019 Nov; 9(1):17405. PubMed ID: 31757986
[TBL] [Abstract][Full Text] [Related]
4. Comparison between two amplicon-based sequencing panels of different scales in the detection of somatic mutations associated with gastric cancer.
Hirotsu Y; Kojima Y; Okimoto K; Amemiya K; Mochizuki H; Omata M
BMC Genomics; 2016 Oct; 17(1):833. PubMed ID: 27782820
[TBL] [Abstract][Full Text] [Related]
5. Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets.
Lu J; Ding Y; Chen Y; Jiang J; Chen Y; Huang Y; Wu M; Li C; Kong M; Zhao W; Wang H; Zhang J; Li Z; Lu Y; Yu X; Jin K; Zhou D; Zhou T; Teng F; Zhang H; Zhou Z; Wang H; Teng L
Nat Commun; 2021 Jun; 12(1):3946. PubMed ID: 34168152
[TBL] [Abstract][Full Text] [Related]
6. Systematic pharmacogenomics analysis of a Malay whole genome: proof of concept for personalized medicine.
Salleh MZ; Teh LK; Lee LS; Ismet RI; Patowary A; Joshi K; Pasha A; Ahmed AZ; Janor RM; Hamzah AS; Adam A; Yusoff K; Hoh BP; Hatta FH; Ismail MI; Scaria V; Sivasubbu S
PLoS One; 2013; 8(8):e71554. PubMed ID: 24009664
[TBL] [Abstract][Full Text] [Related]
7. Oncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq study.
Gray SW; Park ER; Najita J; Martins Y; Traeger L; Bair E; Gagne J; Garber J; Jänne PA; Lindeman N; Lowenstein C; Oliver N; Sholl L; Van Allen EM; Wagle N; Wood S; Garraway L; Joffe S
Genet Med; 2016 Oct; 18(10):1011-9. PubMed ID: 26866579
[TBL] [Abstract][Full Text] [Related]
8. Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.
Van Allen EM; Wagle N; Stojanov P; Perrin DL; Cibulskis K; Marlow S; Jane-Valbuena J; Friedrich DC; Kryukov G; Carter SL; McKenna A; Sivachenko A; Rosenberg M; Kiezun A; Voet D; Lawrence M; Lichtenstein LT; Gentry JG; Huang FW; Fostel J; Farlow D; Barbie D; Gandhi L; Lander ES; Gray SW; Joffe S; Janne P; Garber J; MacConaill L; Lindeman N; Rollins B; Kantoff P; Fisher SA; Gabriel S; Getz G; Garraway LA
Nat Med; 2014 Jun; 20(6):682-8. PubMed ID: 24836576
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathology as basis for timely cancer diagnosis and therapy.
Mackinnon AC; Chandrashekar DS; Suster DI
Virchows Arch; 2024 Feb; 484(2):155-168. PubMed ID: 38012424
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapy in gastric cancer: personalizing cancer treatment based on patient genome.
Lim SM; Lim JY; Cho JY
World J Gastroenterol; 2014 Feb; 20(8):2042-50. PubMed ID: 24587678
[TBL] [Abstract][Full Text] [Related]
11. Next-Generation Sequencing-Based Molecular Profiling Using Cell-Free DNA: A Valuable Tool for the Diagnostic and Prognostic Evaluation of Patients With Gastric Cancer.
Jang MA
Ann Lab Med; 2024 Mar; 44(2):119-121. PubMed ID: 37880993
[No Abstract] [Full Text] [Related]
12. GenoPheno: cataloging large-scale phenotypic and next-generation sequencing data within human datasets.
Gutiérrez-Sacristán A; De Niz C; Kothari C; Kong SW; Mandl KD; Avillach P
Brief Bioinform; 2021 Jan; 22(1):55-65. PubMed ID: 32249310
[TBL] [Abstract][Full Text] [Related]
13. Advancing gastric cancer precision medicine with novel genomic screens
Halmai NB; Carvajal-Carmona LG
J Pathol; 2023 Apr; 259(4):359-361. PubMed ID: 36541926
[TBL] [Abstract][Full Text] [Related]
14. Assessing the validity of driver gene identification tools for targeted genome sequencing data.
Rojas-Rodriguez F; Schmidt MK; Canisius S
Bioinform Adv; 2024; 4(1):vbae073. PubMed ID: 38808071
[TBL] [Abstract][Full Text] [Related]
15. Precision medicine based on surgical oncology in the era of genome-scale analysis and genome editing technology.
Tanaka S
Ann Gastroenterol Surg; 2018 Mar; 2(2):106-115. PubMed ID: 29863171
[TBL] [Abstract][Full Text] [Related]
16. Deciphering the origin and therapeutic targets of cancer of unknown primary: a case report that illustrates the power of integrative whole-exome and transcriptome sequencing analysis.
Al Assaad M; Shin N; Sigouros M; Manohar J; Antysheva Z; Kotlov N; Kiriy D; Nikitina A; Kleimenov M; Tsareva A; Makarova A; Fomchenkova V; Dubinina J; Boyko A; Almog N; Wilkes D; Escalon JG; Saxena A; Elemento O; Sternberg CN; Nanus DM; Mosquera JM
Front Oncol; 2023; 13():1274163. PubMed ID: 38318324
[TBL] [Abstract][Full Text] [Related]
17. Assessing the impact of sequencing platforms and analytical pipelines on whole-exome sequencing.
Sun Y; Zhao X; Fan X; Wang M; Li C; Liu Y; Wu P; Yan Q; Sun L
Front Genet; 2024; 15():1334075. PubMed ID: 38818042
[No Abstract] [Full Text] [Related]
18. Next generation sequencing-based emerging trends in molecular biology of gastric cancer.
Verma R; Sharma PC
Am J Cancer Res; 2018; 8(2):207-225. PubMed ID: 29511593
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive molecular biomarker identification in breast cancer brain metastases.
Schulten HJ; Bangash M; Karim S; Dallol A; Hussein D; Merdad A; Al-Thoubaity FK; Al-Maghrabi J; Jamal A; Al-Ghamdi F; Choudhry H; Baeesa SS; Chaudhary AG; Al-Qahtani MH
J Transl Med; 2017 Dec; 15(1):269. PubMed ID: 29287594
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
